1. New therapeutic strategies for malignant pleural mesothelioma
   Mara A. Bonelli et al, 2017, Biochemical Pharmacology CrossRef
2. Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma
   Andreia Gameiro et al, 2021, Veterinary Sciences CrossRef
3. Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
   Feifei Li et al, 2022, Frontiers in Immunology CrossRef
4. Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma
   Monica Benvenuto et al, 2023, International Journal of Food Sciences and Nutrition CrossRef
5. The role of the phosphatase and tensin homolog status in predicting pathological complete response to neoadjuvant anti-HER2 therapies in HER2-positive primary breast cancer
   Chi Zhang et al, 2019, Medicine CrossRef
6. Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines
   Denis M. Collins et al, 2017, Cellular Immunology CrossRef
7. Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction
   Sylvie Job et al, 2019, Cancers CrossRef
8. Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
   Denis M. Collins et al, 2019, Cancers CrossRef
9. Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
   Roberto Bei et al, 2022, Journal of Translational Medicine CrossRef
10. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer
    Hai-Ying Cao et al, 2017, Oncology Reports CrossRef
11. Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
    Andreia Gameiro et al, 2021, Pharmaceutics CrossRef
12. ErbBs in Lens Cell Fibrosis and Secondary Cataract
    Judy K. VanSlyke et al, 2023, Investigative Opthalmology & Visual Science CrossRef
13. Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
    Babak Nami et al, 2018, Cancers CrossRef
14. HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models
    Andreia Gameiro et al, 2021, Cancers CrossRef
15. Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
    Noora Nykänen et al, 2021, Frontiers in Oncology CrossRef
16. Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma
    Marco Tucci et al, 2017, Experimental Hematology CrossRef